Topic signal

Fosun Pharma's H1 Revenue Rises 4.75%, Product Prepared for Healthcare Negotiations

复星医药上半年营收增4.75%，有产品全力准备医保谈判

A public trend signal observed across 1 source.

businessFirst seen 19d agoLast seen 19d ago

Provenance

Where this topic appeared

1 sources

TP

The Papernews_info

#19Rank reported by source

Observed 19d agoOriginal source

Fosun Pharma's H1 Revenue Rises 4.75%, Product Prepared for Healthcare Negotiations | ThreadEast